HIES

Clinical trials for HIES explained in plain language.

Never miss a new study

Get alerted when new HIES trials appear

Sign up with your email to follow new studies for HIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could an arthritis drug help rare immune disorder?

Disease control Recruiting now

This study tests whether baricitinib, a drug already approved for other immune conditions, is safe for people with Job syndrome who also have lupus-like disease or eczema. About 20 people aged 12 and older will take the pill daily for 6 months. Researchers will monitor side effec…

Matched conditions: HIES

Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated May 26, 2026 08:18 UTC

HIES

Get alerted when new HIES trials appear

Could an arthritis drug help rare immune disorder?